272 related articles for article (PubMed ID: 24612897)
1. Best practices to minimize risk of infection with intrauterine device insertion.
Caddy S; Yudin MH; Hakim J; Money DM; ;
J Obstet Gynaecol Can; 2014 Mar; 36(3):266-274. PubMed ID: 24612897
[TBL] [Abstract][Full Text] [Related]
2. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
3. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
4. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
5. Adolescent Pregnancy Guidelines.
Fleming N; O'Driscoll T; Becker G; Spitzer RF;
J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
[TBL] [Abstract][Full Text] [Related]
6. A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
Turok DK; Eisenberg DL; Teal SB; Keder LM; Creinin MD
Am J Obstet Gynecol; 2016 Nov; 215(5):599.e1-599.e6. PubMed ID: 27180886
[TBL] [Abstract][Full Text] [Related]
7. [Intrauterine contraception: CNGOF Contraception Guidelines].
Vidal F; Paret L; Linet T; Tanguy le Gac Y; Guerby P
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):806-822. PubMed ID: 30429071
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
9. Preventing pelvic infection after abortion.
Stevenson MM; Radcliffe KW
Int J STD AIDS; 1995; 6(5):305-12. PubMed ID: 8547409
[TBL] [Abstract][Full Text] [Related]
10. Complications of use of intrauterine devices among HIV-1-infected women.
Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
[TBL] [Abstract][Full Text] [Related]
11. Infection risk and intrauterine devices.
Martínez F; López-Arregui E
Acta Obstet Gynecol Scand; 2009; 88(3):246-50. PubMed ID: 19172421
[TBL] [Abstract][Full Text] [Related]
12. The prevention of early-onset neonatal group B streptococcal disease.
Money D; Allen VM;
J Obstet Gynaecol Can; 2013 Oct; 35(10):939-948. PubMed ID: 24165063
[TBL] [Abstract][Full Text] [Related]
13. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic prophylaxis for intrauterine contraceptive device insertion.
Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2001; (2):CD001327. PubMed ID: 11405986
[TBL] [Abstract][Full Text] [Related]
15. Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach.
Sufrin CB; Averbach SH
Clin Obstet Gynecol; 2014 Dec; 57(4):682-93. PubMed ID: 25222531
[TBL] [Abstract][Full Text] [Related]
16. Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial.
Kakaire O; Byamugisha JK; Tumwesigye NM; Gemzell-Danielsson K
Hum Reprod; 2015 Jul; 30(7):1573-9. PubMed ID: 25979373
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic prophylaxis in gynaecologic procedures.
Van Eyk N; van Schalkwyk J;
J Obstet Gynaecol Can; 2012 Apr; 34(4):382-391. PubMed ID: 22472341
[TBL] [Abstract][Full Text] [Related]
18. Pratiques optimales en vue de minimiser le risque d'infection au moment de l'insertion d'un dispositif intra-utérin.
Caddy S; Yudin MH; Hakim J; Money DM
J Obstet Gynaecol Can; 2016 Dec; 38(12S):S407-S417. PubMed ID: 28063552
[No Abstract] [Full Text] [Related]
19. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
van Schalkwyk J; Yudin MH;
J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
[TBL] [Abstract][Full Text] [Related]
20. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
Guderian AM; Trobough GE
Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
